Financial Performance and Funding - Future financial performance is dependent on successfully raising additional equity or debt financing to fund operations[21]. - The company currently has no source of product sales revenue, indicating a need for successful commercialization of product candidates[21]. Competition and Market Risks - The company is facing competition from existing products and potential new products that may emerge in the market[21]. - General economic uncertainty may adversely affect spending on medical procedures, impacting the company's market[21]. Regulatory and Compliance Risks - There are risks associated with compliance to U.S. and foreign regulatory requirements, which could limit or withdraw marketing approvals[21]. Operational Dependencies - The company is reliant on third-party supply and manufacturing partners for materials and components necessary for research and development[21]. - Future growth is contingent upon the ability to attract and retain key management and technical personnel[21]. Financial Reporting and Stockholder Concerns - The company has identified material weaknesses in its control over financial reporting, which could impact financial performance[21]. - The company is exposed to volatility in the market price of its stock, which could affect investor confidence[21]. - Potential dilution to current stockholders may occur from the issuance of equity awards[21].
Autonomix Medical(AMIX) - 2024 Q4 - Annual Report